Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn’s Disease of the Pouch

Park S, Keyashian K, Ho A, Limsui D, Frost S, Vazquez R, Yang E, Ebriani J, Maas L, Parian A, Lazarev M, Parekh N, Sauk JS, Limketkai B. Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn's Disease of the Pouch. Inflamm Bowel Dis. 2025 Jul 25:izaf146. doi: 10.1093/ibd/izaf146. Epub ahead of print. PMID: 40708501.


Related Posts

Gregory F. Sonnenberg, PhD Appointed Director of the UCLA Center for Research in Inflammatory Bowel Disease featured image